Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about CTI BioPharma Corp aggregated by PharmaCompass.com.

    Client Virtual Booth

    CTI BIOPHARMA CORP

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    CTI BioPharma Corp
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3101 Western Ave., #800 Seattle, WA 98121
    Telephone
    Telephone
    +1 206-282-7100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ctibiopharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cell-therapeutics-inc.
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Sobi completes acquisition of CTI BioPharma Corp.
    Sobi completes acquisition of CTI BioPharma Corp.

    https://www.prnewswire.com/news-releases/sobi-completes-acquisition-of-cti-biopharma-corp-301863272.html

    PR NEWSWIRE
    26 Jun 2023
    Share Share
    In $1.7B buy, Sobi acquires CTI and myelofibrosis drug Vonjo
    In $1.7B buy, Sobi acquires CTI and myelofibrosis drug Vonjo

    https://www.fiercepharma.com/pharma/sobi-snatches-cti-and-blood-cancer-drug-vonjo-17b-purchase

    Kevin Dunleavy FIERCE PHARMA
    11 May 2023
    Share Share
    Sweden's SOBI makes $1.7 bln offer to buy CTI BioPharma
    Sweden's SOBI makes $1.7 bln offer to buy CTI BioPharma

    https://www.reuters.com/markets/deals/swedens-sobi-makes-17-bln-offer-buy-cti-biopharma-2023-05-10/

    REUTERS
    10 May 2023
    Share Share
    CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.prnewswire.com/news-releases/cti-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-301816726.html

    PR NEWSWIRE
    05 May 2023
    Share Share
    CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.prnewswire.com/news-releases/cti-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-301813803.html

    PR NEWSWIRE
    02 May 2023
    Share Share
    CTI BioPharma to Participate in Two Upcoming Investor Conferences in April 2023
    CTI BioPharma to Participate in Two Upcoming Investor Conferences in April 2023

    https://www.prnewswire.com/news-releases/cti-biopharma-to-participate-in-two-upcoming-investor-conferences-in-april-2023-301796072.html

    PR NEWSWIRE
    12 Apr 2023
    Share Share
    CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.prnewswire.com/news-releases/cti-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-301793714.html

    PR NEWSWIRE
    10 Apr 2023
    Share Share
    CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.prnewswire.com/news-releases/cti-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-301776750.html

    PR NEWSWIRE
    20 Mar 2023
    Share Share
    CTI BioPharma Reports Fourth Quarter and Full Year 2022 Financial Results
    CTI BioPharma Reports Fourth Quarter and Full Year 2022 Financial Results

    https://www.prnewswire.com/news-releases/cti-biopharma-reports-fourth-quarter-and-full-year-2022-financial-results-301762960.html

    PR NEWSWIRE
    06 Mar 2023
    Share Share
    CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.prnewswire.com/news-releases/cti-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-301763831.html

    PR NEWSWIRE
    06 Mar 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search